News

Filter

Sanofi buys Colombian drugmaker; Presents encouraging eliglustat and Lyxumia data; Revizes deal with B-MS

03-10-2012

In what turns out to be a very busy couple of days for French drug major Sanofi (Euronext: SAN), the…

AvaproBiotechnologyBristol-Myers SquibbCardio-vascularDiabeteseliglustatGenericsGenfar SAGlobalLyxumiaMarkets & MarketingMergers & AcquisitionsPharmaceuticalPlavixRare diseasesResearchSanofiSouth America

Back to top